2026 Q2 Portfolio Activity
In 2026 Q2, PFM Health Sciences, LP maintained a portfolio of 118 distinct positions. The most significant new addition was HUMANA INC, now representing 3.22% of the total fund value. They heavily accumulated shares in UNITEDHEALTH GROUP INC, increasing the position by 52.1%. Conversely, PFM Health Sciences, LP completely exited their position in SPDR SERIES TRUST.
Position History
hover any row below to update
Loading…
Total Positions
118
Quarter
2026 Q2
Top Holding
N/A (5.3%)
Top 10 Concentration
33.9%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 118
PFM Health Sciences, LP Full Holdings List — 2026 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
N/A
ASCENDIS PHARMA...
|
|
Unknown | 5.34% | — |
#1
Prev: #—
|
7.6 |
—
|
233,171 | — |
NEW
|
233,171 | $62,191,369 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
AXSM
AXSOME THERAPEU...
|
Healthcare | 4.61% | 4.07% |
#2
3
Prev: #5
|
3.8 |
—
|
-44,708 | -16.9% |
P
S
|
219,596 | $53,750,513 | 2022 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
LLY
ELI LILLY & CO
|
Healthcare | 4.04% | 5.52% |
#3
1
Prev: #2
|
2.6 |
—
|
-26,504 | -40.3% |
P
S
|
39,258 | $47,087,223 | 2008 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
JAZZ
JAZZ PHARMACEUT...
|
Healthcare | 3.32% | 3.07% |
#4
4
Prev: #8
|
2.3 |
—
|
-17,376 | -9.8% |
P
S
|
160,768 | $38,740,265 | 2015 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
HUM
HUMANA INC
|
Healthcare | 3.22% | — |
#5
Prev: #—
|
5.3 |
—
|
94,375 | — |
NEW
|
94,375 | $37,487,638 | 2009 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
UNH
UNITEDHEALTH GR...
|
Healthcare | 3.15% | 1.43% |
#6
15
Prev: #21
|
4.3 |
—
|
30,238 | 52.1% |
P
S
|
88,276 | $36,690,154 | 2008 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
NBIX
NEUROCRINE BIOS...
|
Healthcare | 3.09% | 2.59% |
#7
2
Prev: #9
|
1.7 |
—
|
-2,271 | -1.1% |
P
S
|
213,407 | $35,966,549 | 2021 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
INBX
INHIBRX BIOSCIE...
|
Healthcare | 2.51% | 1.87% |
#8
6
Prev: #14
|
1.5 |
—
|
2,954 | 1.0% |
P
S
|
308,385 | $29,219,479 | 2023 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
UTHR
UNITED THERAPEU...
|
Healthcare | 2.32% | 2.15% |
#9
2
Prev: #11
|
3.4 |
—
|
10,186 | 25.6% |
P
S
|
49,991 | $27,086,624 | 2008 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
RVMD
REVOLUTION MEDI...
|
Healthcare | 2.30% | 1.25% |
#10
14
Prev: #24
|
1.4 |
—
|
2,452 | 1.7% |
P
S
|
143,222 | $26,822,616 | 2020 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ICLR
ICON PUB LTD CO
|
Healthcare | 2.03% | 0.58% |
#11
43
Prev: #54
|
3.8 |
—
|
78,982 | 137.4% |
P
S
|
136,482 | $23,708,288 | 2016 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
THC
TENET HEALTHCAR...
|
Healthcare | 2.03% | 6.86% |
#12
11
Prev: #1
|
0.8 |
—
|
-271,995 | -68.2% |
P
S
|
126,572 | $23,679,090 | 2008 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
EW
EDWARDS LIFESCI...
|
Healthcare | 1.94% | 1.86% |
#13
2
Prev: #15
|
1.3 |
—
|
-4,057 | -1.6% |
P
S
|
250,453 | $22,655,978 | 2008 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
WAT
WATERS CORP
|
Healthcare | 1.93% | 1.08% |
#14
17
Prev: #31
|
3.8 |
—
|
20,062 | 50.5% |
P
S
|
59,825 | $22,436,768 | 2009 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
PEN
PENUMBRA INC
|
Healthcare | 1.63% | 4.19% |
#15
11
Prev: #4
|
0.7 |
—
|
-79,558 | -56.9% |
P
S
|
60,221 | $19,014,781 | 2015 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BBIO
BRIDGEBIO PHARM...
|
Healthcare | 1.62% | 1.75% |
#16
Prev: #16
|
1.1 |
—
|
-4,389 | -1.7% |
P
S
|
253,358 | $18,870,104 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SYK
STRYKER CORPORA...
|
Healthcare | 1.53% | 0.66% |
#17
33
Prev: #50
|
3.6 |
—
|
34,680 | 157.9% |
P
S
|
56,637 | $17,831,593 | 2009 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MTD
METTLER TOLEDO ...
|
Healthcare | 1.46% | — |
#18
Prev: #—
|
4.1 |
—
|
13,344 | — |
NEW
|
13,344 | $17,047,093 | 2009 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
INDV
INDIVIOR PHARMA...
|
Healthcare | 1.41% | 1.60% |
#19
Prev: #19
|
0.6 |
—
|
-173,458 | -30.2% |
P
S
|
401,208 | $16,461,564 | 2025 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MRK
MERCK & CO INC
|
Healthcare | 1.40% | — |
#20
Prev: #—
|
4.1 |
—
|
127,118 | — |
NEW
|
127,118 | $16,334,663 | 2010 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CYTK
CYTOKINETICS IN...
|
Healthcare | 1.40% | — |
#21
Prev: #—
|
4.1 |
—
|
191,686 | — |
NEW
|
191,686 | $16,329,730 | 2020 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
LNTH
LANTHEUS HLDGS ...
|
Healthcare | 1.39% | — |
#22
Prev: #—
|
4.1 |
—
|
146,403 | — |
NEW
|
146,403 | $16,241,949 | 2023 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CNC
CENTENE CORP DE...
|
Healthcare | 1.37% | 0.79% |
#23
18
Prev: #41
|
1.0 |
—
|
-14,619 | -5.5% |
P
S
|
248,867 | $15,974,773 | 2009 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
COO
COOPER COS INC
|
Healthcare | 1.36% | 1.11% |
#24
3
Prev: #27
|
3.0 |
—
|
51,061 | 30.1% |
P
S
|
220,890 | $15,840,022 | 2011 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MDGL
MADRIGAL PHARMA...
|
Healthcare | 1.35% | 1.63% |
#25
7
Prev: #18
|
1.0 |
—
|
-4,833 | -14.2% |
P
S
|
29,313 | $15,739,615 | 2021 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ACHC
ACADIA HEALTHCA...
|
Healthcare | 1.33% | 1.24% |
#26
1
Prev: #25
|
1.0 |
—
|
-57,811 | -9.9% |
P
S
|
524,934 | $15,501,301 | 2015 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ORKA
ORUKA THERAPEUT...
|
Healthcare | 1.30% | 0.78% |
#27
16
Prev: #43
|
1.0 |
—
|
-15,227 | -8.7% |
P
S
|
158,825 | $15,115,375 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
OSCR
OSCAR HEALTH IN...
|
Healthcare | 1.27% | 0.52% |
#28
31
Prev: #59
|
1.0 |
—
|
19,179 | 3.8% |
P
S
|
519,016 | $14,802,336 | 2023 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TMO
THERMO FISHER S...
|
Healthcare | 1.23% | 0.66% |
#29
19
Prev: #48
|
3.5 |
—
|
13,664 | 92.1% |
P
S
|
28,496 | $14,286,755 | 2009 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CVS
CVS HEALTH CORP
|
Healthcare | 1.22% | — |
#30
Prev: #—
|
4.0 |
—
|
137,457 | — |
NEW
|
137,457 | $14,219,927 | 2009 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MMSI
MERIT MED SYS I...
|
Healthcare | 1.17% | 1.02% |
#31
5
Prev: #36
|
3.0 |
—
|
34,569 | 21.3% |
P
S
|
197,038 | $13,662,615 | 2011 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
PRAX
PRAXIS PRECISIO...
|
Healthcare | 1.11% | 1.04% |
#32
1
Prev: #33
|
2.4 |
—
|
3,137 | 8.9% |
P
S
|
38,575 | $12,914,524 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CLDX
CELLDEX THERAPE...
|
Healthcare | 1.09% | 0.94% |
#33
4
Prev: #37
|
2.4 |
—
|
17,794 | 5.5% |
P
S
|
342,751 | $12,753,765 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
NVO
NOVO-NORDISK A ...
|
Healthcare | 1.09% | 0.66% |
#34
15
Prev: #49
|
2.9 |
—
|
67,835 | 34.4% |
P
S
|
265,016 | $12,704,867 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ITGR
INTEGER HLDGS C...
|
Healthcare | 1.02% | 1.08% |
#35
6
Prev: #29
|
0.9 |
—
|
-8,412 | -6.2% |
P
S
|
126,669 | $11,837,218 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
DNTH
DIANTHUS THERAP...
|
Healthcare | 1.01% | 1.32% |
#36
14
Prev: #22
|
0.4 |
—
|
-50,915 | -29.6% |
P
S
|
121,222 | $11,816,721 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
DFTX
DEFINIUM THERAP...
|
Healthcare | 1.01% | 0.35% |
#37
30
Prev: #67
|
2.9 |
—
|
43,703 | 21.3% |
P
S
|
249,020 | $11,713,901 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
GILD
GILEAD SCIENCES...
|
Healthcare | 0.98% | — |
#38
Prev: #—
|
3.9 |
—
|
90,858 | — |
NEW
|
90,858 | $11,479,000 | 2008 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
RYTM
RHYTHM PHARMACE...
|
Healthcare | 0.97% | 1.08% |
#39
9
Prev: #30
|
0.4 |
—
|
-35,071 | -25.7% |
P
S
|
101,550 | $11,275,097 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
HSIC
SCHEIN HENRY IN...
|
Healthcare | 0.96% | 1.03% |
#40
6
Prev: #34
|
0.9 |
—
|
-18,691 | -12.2% |
P
S
|
134,423 | $11,227,009 | 2009 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ARWR
ARROWHEAD PHARM...
|
Healthcare | 0.92% | 0.37% |
#41
24
Prev: #65
|
3.4 |
—
|
67,388 | 104.8% |
P
S
|
131,667 | $10,732,177 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TNGX
TANGO THERAPEUT...
|
Healthcare | 0.87% | 0.77% |
#42
2
Prev: #44
|
0.8 |
—
|
-80,198 | -19.7% |
P
S
|
326,047 | $10,192,229 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TFX
TELEFLEX INCORP...
|
Healthcare | 0.87% | — |
#43
Prev: #—
|
3.8 |
—
|
79,708 | — |
NEW
|
79,708 | $10,103,786 | 2018 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
VKTX
VIKING THERAPEU...
|
Healthcare | 0.85% | 0.78% |
#44
2
Prev: #42
|
0.8 |
—
|
-7,776 | -3.0% |
P
S
|
255,330 | $9,960,423 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BTSG
BRIGHTSPRING HE...
|
Healthcare | 0.85% | 0.73% |
#45
1
Prev: #46
|
0.3 |
—
|
-45,421 | -24.2% |
P
S
|
141,914 | $9,897,082 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
VERA
VERA THERAPEUTI...
|
Healthcare | 0.83% | 0.64% |
#46
5
Prev: #51
|
2.8 |
—
|
49,422 | 28.3% |
P
S
|
224,289 | $9,624,241 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ROIV
ROIVANT SCIENCE...
|
Healthcare | 0.81% | 0.52% |
#47
11
Prev: #58
|
2.8 |
—
|
60,562 | 29.2% |
P
S
|
268,008 | $9,484,803 | 2023 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CGON
CG ONCOLOGY INC
|
Healthcare | 0.78% | 1.02% |
#48
13
Prev: #35
|
0.3 |
—
|
-37,639 | -22.7% |
P
S
|
128,286 | $9,114,720 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
AMRX
AMNEAL PHARMACE...
|
Healthcare | 0.71% | 1.05% |
#49
17
Prev: #32
|
0.3 |
—
|
-449,381 | -48.3% |
P
S
|
480,715 | $8,321,177 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
EPRX
EUPRAXIA PHARMA...
|
Healthcare | 0.69% | 0.36% |
#50
16
Prev: #66
|
3.3 |
—
|
669,790 | 123.8% |
P
S
|
1,210,661 | $8,002,469 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 |
Showing 1-50 of 118 holdings